The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
about
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The Cambridge Prognostic Group ...... te cancer: a validation study.
@en
The Cambridge Prognostic Group ...... te cancer: a validation study.
@nl
type
label
The Cambridge Prognostic Group ...... te cancer: a validation study.
@en
The Cambridge Prognostic Group ...... te cancer: a validation study.
@nl
prefLabel
The Cambridge Prognostic Group ...... te cancer: a validation study.
@en
The Cambridge Prognostic Group ...... te cancer: a validation study.
@nl
P2093
P2860
P1433
P1476
The Cambridge Prognostic Group ...... te cancer: a validation study.
@en
P2093
A Lophatananon
V J Gnanapragasam
P2860
P2888
P356
10.1186/S12916-018-1019-5
P407
P577
2018-02-28T00:00:00Z
P6179
1101279250